CROs
Introduce your dedicated clinical trial solutions to advance the work in orphan drug and rare disease research and development
Market Access Consultants
Present your innovative market access strategies to orphan drug regulators and licensing authorities across Asia
Regulatory Consultants
Show the industry how policies can evolve to improve the efficacy of licensure and regulatory processes
Specialty Pharma Distributors
Demonstrate your capability as a specialised distributor in the industry and share the importance of enhancing these distribution networks
Software solutions
Whether it be for streamlined connections with patients, or for aggregating scientific data, the orphan drug and rare disease sector can benefit from this.
Medical communications experts
Because articulating the value of orphan drugs requires meticulous work, and is industry’s best bet in helping government understand the need of orphan drugs
Contact
Pinky Fadullon
at
pinky.fadullon@terrapinn.com
or
+65 6322 2738